Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samson T Jacob

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Cancers|September 26, 2020
Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular CarcinomaKelly Regan-Fendt, Ding Li, Ryan Reyes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2013
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulationsXinmei Wang, Bo Yu, Wei Ren, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homologXinmei Wang, Hongyan He, Yuanzhi Lu, et al.
Cancer Research|July 3, 2008
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisJharna Datta, Huban Kutay, Mohd W Nasser, et al.
Cancer Research|December 15, 2023
Retraction: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular CarcinogenesisJharna Datta, Huban Kutay, Mohd W Nasser, et al.
Oncotarget|June 15, 2018
CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128Mohamed Badawi, Jihye Kim, Anees Dauki, et al.
Biomaterials|June 2, 2012
Lipid nanoparticles for hepatic delivery of small interfering RNABo Yu, Shu-Hao Hsu, Chenguang Zhou, et al.
Molecular Cancer Therapeutics|December 17, 2016
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse ModelKun-Yu Teng, Jianfeng Han, Xiaoli Zhang, et al.
Molecular Cancer Therapeutics|October 5, 2019
Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the StromaCho-Hao Lin, Khadija H Elkholy, Nissar A Wani, et al.
Blood|October 18, 2011
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemiaTasneem Motiwala, Nicola Zanesi, Jharna Datta, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Cancers|September 26, 2020
Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular CarcinomaKelly Regan-Fendt, Ding Li, Ryan Reyes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2013
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulationsXinmei Wang, Bo Yu, Wei Ren, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homologXinmei Wang, Hongyan He, Yuanzhi Lu, et al.
Cancer Research|July 3, 2008
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisJharna Datta, Huban Kutay, Mohd W Nasser, et al.
Cancer Research|December 15, 2023
Retraction: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular CarcinogenesisJharna Datta, Huban Kutay, Mohd W Nasser, et al.
Oncotarget|June 15, 2018
CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128Mohamed Badawi, Jihye Kim, Anees Dauki, et al.
Biomaterials|June 2, 2012
Lipid nanoparticles for hepatic delivery of small interfering RNABo Yu, Shu-Hao Hsu, Chenguang Zhou, et al.
Molecular Cancer Therapeutics|December 17, 2016
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse ModelKun-Yu Teng, Jianfeng Han, Xiaoli Zhang, et al.
Molecular Cancer Therapeutics|October 5, 2019
Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the StromaCho-Hao Lin, Khadija H Elkholy, Nissar A Wani, et al.
Blood|October 18, 2011
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemiaTasneem Motiwala, Nicola Zanesi, Jharna Datta, et al.
Pageof 9